Celastrol attenuates the invasion and migration and augments the anticancer effects of bortezomib in a xenograft mouse model of multiple myeloma

QR Code

Celastrol attenuates the invasion and migration and augments the anticancer effects of bortezomib in a xenograft mouse model of multiple myeloma

© 2018 Shanmugam, Ahn, Lee, Kannaiyan, Mustafa, Manu, Siveen, Sethi, Chng and Kumar. Several lines of evidence have demonstrated that deregulated activation of NF-?B plays a pivotal role in the initiation and progression of a variety of cancers including multiple myeloma (MM). Therefore, novel molec...

Full description

Bibliographic Details
Main Authors:	Shanmugam, M., Ahn, K., Lee, J., Kannaiyan, R., Mustafa, N., Manu, K., Siveen, K., Sethi, G., Chng, W., Kumar, Alan Prem
Format:	Journal Article
Published:	2018
Online Access:	http://hdl.handle.net/20.500.11937/69123

Similar Items

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
by: Siveen, K., et al.
Published: (2014)

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
by: Kannaiyan, R., et al.
Published: (2011)

Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model
by: Shanmugam, M., et al.
Published: (2015)

Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
by: Manu, K., et al.
Published: (2013)

Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of Multiple Myeloma
by: Sikka, S., et al.
Published: (2014)

Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
by: Li, F., et al.
Published: (2015)

First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway
by: Manu, K., et al.
Published: (2012)

Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways
by: Kannaiyan, R., et al.
Published: (2011)

Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: The role of p38 MAPK and ROS
by: Woo, C., et al.
Published: (2013)

Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo
by: Rajendran, P., et al.
Published: (2012)

Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma
by: Manu, K., et al.
Published: (2013)

Anticancer effects of combined gamma-tocotrienol and 13-cis retinoic acid against neuroblastoma cells and xenografts
by: Ch'ng, Qin Ting
Published: (2021)

Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4
by: Manu, K., et al.
Published: (2011)

Inhibition of p300 Lysine Acetyltransferase activity by Luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model
by: Selvi, R., et al.
Published: (2015)

Recurrent chalazia secondary to bortezomib
by: Fatin Hanisah F,, et al.
Published: (2018)

Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation
by: Abd Aziz, Noraini, et al.
Published: (2015)

γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
by: Siveen, K., et al.
Published: (2014)

Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
by: Kim, C., et al.
Published: (2018)

Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice
by: Shanmugam, M., et al.
Published: (2011)

Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor ? activation pathway in gastric cancer (Journal of Biological Chemistry (2012) 287, (38028-38040))
by: Ramachandran, L., et al.
Published: (2013)

Isorhamnetin Inhibits Proliferation and Invasion and Induces Apoptosis through the Modulation of Peroxisome Proliferator-activated Receptor [gamma] Activation Pathway in Gastric Cancer
by: Ramachandran, L., et al.
Published: (2012)

Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
by: Zhang, J., et al.
Published: (2017)

Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model
by: Shanmugam, M., et al.
Published: (2011)

Effects of bortezomib on HIF-1 and HIF-2 transcriptional activities
by: Abd Aziz, Noraini
Published: (2013)

Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
by: Dai, X., et al.
Published: (2015)

Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model
by: Zhang, J., et al.
Published: (2016)

Assessment Of Antitumor Activity Of Standardized Polyalthia Longifolia Leaf Extract In Hela Cell Tumor Xenograft Mouse Model
by: Braganza, Cilwyn Shalitha
Published: (2022)

Organochlorine Levels in Plasma and Risk of Multiple Myeloma
by: Weber, L., et al.
Published: (2018)

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
by: Manu, K., et al.
Published: (2018)

FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells
by: Davies, F.E, et al.
Published: (1999)

An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins
by: Subramaniam, Aruljothi, et al.
Published: (2013)

Cytotoxic activity induced by crude extracts of Ganoderma lucidum (W. Curt.: Fr.) P. Karst. on mouse myeloma cancer cell-line
by: Tong, Chow Chin, et al.
Published: (2009)

Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-?B signaling cascade in gastric cancer
by: Manu, K., et al.
Published: (2015)

Serum separation abnormality in a multiple myeloma patient
by: Zaharudin, Mohd Radzli, et al.
Published: (2023)

γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
by: Rajendran, P., et al.
Published: (2011)

A rare occurrence of plasma cell myeloma with biclonal gammopathy
by: Mardziah M,, et al.
Published: (2017)

Light chain multiple myeloma: an evaluation of its biochemical investigations
by: Zahari Sham, Siti Yazmin, et al.
Published: (2017)

Myeloma kidney – a treatable yet often forgotten disease
by: Lim, Christopher Thiam Seong, et al.
Published: (2017)

Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway
by: Woo, C., et al.
Published: (2011)

Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-ÎºB in hepatocellular carcinoma cells
by: Mohan, C., et al.
Published: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hedcj2i3hctc6oihl013bka7ht